A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)

This is a safety and efficacy study of bimatoprost in male subjects with androgenic alopecia (AGA).

Inclusion Criteria:

• Mild to moderate male pattern baldness (androgenic alopecia) with ongoing hair loss for at least 1 year
• Willingness to maintain same hair style, length and hair color during study
• Willingness to have micro-dot-tattoo applied to scalp (Stage 2 only)

Exclusion Criteria:

• Drug or alcohol abuse within 12 months
• HIV positive
• Received hair transplants or had scalp reductions
• Use of hair weaves, hair extensions or wigs within 3 months
• Use of minoxidil (oral or topical) and/or low level light treatment "combs" for hair growth within the last 6 months, or expected use during the study
• Application of topical steroids or nonsteroidal anti-inflammatory drugs (NSAIDs) to scalp within 4 weeks